Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT01632033
NCT01632033CompletedNot Applicable

Estimation de la capacité Fonctionnelle a la Marche Par Questionnaire Clinique Chez Des Patients adressés Pour Bilan artériel Des Membres inférieurs: Etude WELCH-bis

University Hospital, Angers1 site in 1 country150 target enrollmentStarted: July 2012Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
150
Locations
1
Primary Endpoint
Scoring of the WELCH. Percent scored questionnaires
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The purpose of this study is to test the routine faisibility of a questionnaire to estimate walking impairment(The WELCH questionnaire) in patients investigated for suspected PAD.

Detailed Description

The WELCH and WIQ questionnaires are self completed by the patients and scored by the physician after self-completion.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Sigjned consent for the data treatment as a database

Exclusion Criteria

  • •Non french native language age < 18 years old

Outcomes

Primary Outcomes

Scoring of the WELCH. Percent scored questionnaires

Time Frame: 1 day

Predetermined scored . Scoring is optional and compared to scoring of the WIQ

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
University Hospital, Angers
Sponsor Class
Other Gov
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Unknown
Phase 4
Walking Estimated Limitation Calculated by History - Study 2Peripheral Artery Disease
NCT01424020University Hospital, Angers800
Terminated
Not Applicable
Walking Impairment Questionnaire in PADPeripheral Artery Disease
NCT01114178University Hospital, Angers340
Completed
Not Applicable
Feasibility of Home-based Measurement of Walking Capacity Using Global Positioning System in Peripheral Artery DiseasePeripheral Artery Disease
NCT01141361University Hospital, Angers251
Completed
Not Applicable
Assessing Functional Capacity in Directly and Remotely Monitored Home-based Settings: A Protocol for a Multinational Validation Study in Individuals With Chronic Respiratory DiseasesCOPD Chronic Obstructive Pulmonary DiseaseInterstitial Lung Disease
NCT06447831Laval University89
Completed
Phase 4
A Prospective, Open-label, Non-randomized, Clinical Trial to Determine if Natalizumab (Tysabri®) Improves Ambulatory Measures in Relapsing-remitting Multiple Sclerosis (RRMS) PatientsRelapsing Remitting Multiple Sclerosis (RRMS)
NCT00871780Biogen224